SAU:4005
National Medical Care Company · SAU · Healthcare · SAR · FY for 2025
Figures on this page computed 2026-11-08 13:39 UTC
Last close
n/aSAR
Market data
14.7xP/E
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- SAR
- computed
- Computed from the filing for 2025
16.0%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- SAR
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
19.9%Net margin
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- SAR
- Computed from the filing for 2025
- Computed from the filing for 2025
1.7%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- SAR
- Computed from the filing for 2025
- Computed from the filing for 2025
0.36Debt/equity
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- SAR
- Computed from the filing for 2025
- Computed from the filing for 2025
1.9%Dividend yield
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- SAR
- computed
What it pays out is the furthest below its sector's middle: 0.40 against 0.44 on the market's range.
Follow one riyal
lens 1 of 9After what it costs to make
36.8%
After running the business
22.2%
After interest and tax
19.9%
After what it must reinvest
1.7%
Kept after the dividend
-3.9%
The five stops
5 of 5 read- After what it costs to make589,000,00036.8%
- After running the business355,000,00022.2%
- After interest and tax318,000,00019.9%
- After what it must reinvest26,799,7101.7%
- Kept after the dividend-62,580,290-3.9%
Of every unit of sales, -0.04 is still there after the dividend.
Of every unit of sales, -0.04 is still there after the dividend.
Every figure in this lens
Except where said otherwise: Computed from the filing for 2025
Sales1,600,000,000
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- SAR
After what it costs to make589,000,000
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- SAR
After running the business355,000,000
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- SAR
After interest and tax318,000,000
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- SAR
After what it must reinvest26,799,710
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- SAR
Kept after the dividend-62,580,290
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- SAR